Caris Life Sciences
Offers molecular profiling services to identify precise therapeutic options for cancer patients.
What they do
Caris Life Sciences delivers comprehensive molecular profiling services that analyze DNA, RNA, and proteins from tumor biopsies. Oncologists use these genomic profiling results to match patients with precise, targeted therapies and relevant clinical trials based on their individual cancer profiles.
The record
- Vertical
- Oncology
- Sub-segment
- Cancer screening and diagnostics
- Product type
- Diagnostics
- Stage
- Growth
- Headquarters
- Irving, United States
- Region
- North America
- Founded
- 2008
- Total funding
- $1.7B raised
Notable investors: Sixth Street Partners, T. Rowe Price Associates, Silver Lake, Fidelity Management & Research Company.